Six foreign investors to make drugs in Tanzania

Published by Théophile Niyitegeka
On 4 November 2016 saa 02:02
Views :
47 2

Six companies have expressed interest to invest in the pharmaceutical and medical equipment manufacturing, Industries, Trade and Investments Minister, Mr Charles Mwijage, said here yesterday.

Mr Mwijage, addressing the National Assembly, named the potential investors as JNS Solution, which will come up with 1V Fluid and China Dalian International Economic Development Group Co. Limited that will bring in the medical equipment factory.

Others are Zinga Pharmaceutical Limited, the producer of various medicines; Boryung Pharmaceuticals Co Limited, a Korean company that manufactures anti-biotics, Aga Khan Foundation Network for manufacture of pharmaceuticals, as well as Hainan Hualon for production of medicines.

According to the minister, the government has tasked five public institutions to come up with conducive investment environment for private investors seeking to inject their resources in the pharmaceutical and medical equipment industry.

The tasked institutions are the Medical Stores Department (MSD), National Health Insurance Fund (NHIF), Tanzania Investment Bank (TIB), Tanzania Food and Drugs Authority (TFDA) and Tanzania Industrial Research and Development Organisation (TIRDO).

Mr Mwijage was answering a question by Khadija Nassir Ali (Special Seats - CCM), who wanted to know why the government imports drips instead of setting up factories in each hospital to produce the product. Responding, Mr Mwijage said among the products which are expected to be produced by the industries will be 1V1 Fluids and gauze, which will be manufactured from cotton.

The minister also called on interested investors in drip manufacture to visit the Ministry of Health, which has special guidelines for setting up such factory.

The new investments in pharmaceutical and medical equipment industry will offer a big relief to Tanzanians, as the latest findings show that the country wastes a lot of money on importation or procurement of medicines from agents or middlemen.